BES meeting 2025 (Final program)

35th Meeting of the Belgian Endocrine Society
October 9 & 10, 2025

Mdeon visa: 25/V2/10413/010443

Thursday October 9:

13:00-13:30    General assembly

Prof. Dr. Laurent Crenier (HUB, Hôpital Erasme), President
Prof. Dr. Guy T’Sjoen (UZ Gent), Treasurer

13:30-13:55    Registration & Welcome coffee

 

13:55-14:00    Welcome by our president

Prof. Dr. Laurent Crenier (HUB, Hôpital Erasme)

                 

 

14:00-15:00      Mastering pituitary tumor care: Overcoming management challenges based on expert insights

Sponsored by Recordati

14:00-14:05      Introduction

Prof. Dr. Orsalia Alexopoulou (Cliniques universitaires Saint-Luc)

 

14:05-14:30      Discussing the clinical picture of Ectopic Cushing’s syndrome & aggressive pituitary tumors

Prof. Dr. Wouter de Herder (Erasmus MC Rotterdam)

 

14:30-14:55      Clinical cases of Cushing’s disease & aggressive prolactinoma

Dr. Stefan Matei Constantinescu (Cliniques universitaires Saint-Luc)

14:55-15:00      Audience questions and closing remarks

Prof. Dr. Orsalia Alexopoulou  (Cliniques universitaires Saint-Luc)

 

15:00-16:00       European expert consensus on practical management of specific aspects of

parathyroid disorders in adults and in pregnancy: Recommendations of the ESE educational program of parathyroid disorders

Sponsored by Ascendis Pharma

 

15:00-15:05      Introduction

                        Dr. Sara Vandewalle  (AZ Sint-Jan Brugge)

 

15:05-15:30      Patient journey, physiopathology and etiology of hypoparathyroidism

                        Dr. Charlotte Verroken  (UZ Gent)

 

15:30-15:55      New paradigm in hypoparathyroid disorder treatment

Dr. Jean-Philippe Bertocchio   (APHP, Hôpital Pitié-Salpêtrière, Paris)

 

15:55-16:00      Audience questions and closing remarks

                        Dr. Sara Vandewalle  (AZ Sint-Jan Brugge)

 

 

16:00-16:45       Coffee break – Poster Session  –  Registration

16:45-17:00       Welcome at the BES meeting

Prof. Dr. Laurent Crenier (HUB, Hôpital Erasme)

17:00-18:00       Diabetes and technology for inpatients

Prof. dr. Julia Mader (Medical University of Graz)

Introduced by Prof. Dr. Roman Vangoitsenhoven (UZ Leuven)

18:00-19:00       The impact of obesity on fertility

Prof. Dr. Christophe Blockeel (VUB)

Introduced by Prof. Dr. Robert Hilbrands (UZ Brussel)

19:00-20:00       What can the European Reference Networks for Rare Endocrine Conditions

mean to you and your patients?

Prof. Dr.  Alberto Pereira Arias (Amsterdam UMC)

Introduced by Prof. Dr. Patrick Petrossians (CHU Liège)

20:00-22:00       Walking dinner

 

Friday October 10:

08:00-08:30       Registration – Poster Session

                     Visit of the exhibits and poster viewing

08:30-09:00       BSED in action: update on the diabetes convention, diabetes prevention

& nomenclature

Dr. Dominique Ballaux  (BSED)

Introduced by Prof. Dr. Guy T’Sjoen (UZ Gent)

09:00-10:00       New options for treating kidney disease in diabesity

Sponsored by Novo Nordisk

 

09:00-09:05      Introduction

                        Prof. Dr. Roman Vangoitsenhoven (UZ Leuven)

 

09:05-09:50      The specific benefit of combination therapy with SGLT2i in addition to nsMRA and GLP1

                        Prof. Dr. Peter Rossing (Steno Diabetes Center Copenhagen)

 

09:55-10:00      Audience questions and closing remarks

                        Prof. Dr. Roman Vangoitsenhoven (UZ Leuven)

 

10:00-11:15       A breath of fresh air – don’t forget your walking shoes!

 

11:15-12:45       Communications by young investigators

                 

Sponsored by Pfizer

                        Introduced by Prof. Dr. Robert Hilbrands (UZ Brussel)

                   Clinical and Translational studies: 4 selected presentations

Real-World evidence of the effect of adjunctive semaglutide on weight change, glycaemic control, and metabolic-dysfunction associated steatotic liver disease in people with type 1 diabetes. dr. Jonathan Mertens (UZA)

The use of rapid on-site evaluation during thyroid fine needle aspiration might help improve samples representativity. dr. Aurelien Schommers (CHULiege)

One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an advanced hybrid closed-loop system: a real-world prospective cohort study. PhD Jolien Demeulemeester (KUL)

Discrepancy between haemoglobine A1c and continuous glucose monitoring derived glucose management indicator and its link to microvascular complications in type 1 diabetes. dr. Sarah Van Ostaeyen (UZA)

                   Clinical Case Reports: 2 selected presentations

Endoscopic Ultrasound-Guided Trans-Gastric Radiofrequency Ablation:  An Effective and Safe Alternative Treatment for Left-sided  Unilateral Aldosterone-Producing Adenoma. dr. Lynda Bombil (UCL)

Familial hyperaldosteronism type I: Contribution of long-read DNA sequencing. dr. Laura Abdessater (ULB)

12:45-13:30       Lunch

13:30-13:45       Selected Belgian Publication Award

Sponsored by Sandoz

Introduced by Dr. Laura Iconaru (CHU Brugmann)

Evaluation of the thiazide challenge test to differentiate primary from hypercalciuria-related hyperparathyroidism

dr. Ewout Verly (Vitaz, UZ Gent), prof. dr. Bruno Lapauw & dr. Charlotte Verroken (UZ Gent)

13:45-14:15       Belgian Endocrine Society Lecture Award

                  Sponsored by Novo Nordisk

                        Introduced by Prof. Dr. Laurent Crenier (HUB, Hôpital Erasme)

“The Changing Landscape in the Assessment of Steroid Hormone concentrations: is it time to set them free?” Prof. dr. Leen Antonio

                 

14:15-14:45       Invited lecture: Thrombotic risk across sexual hormone treatment               

                        Prof. Dr.  Cédric Hermans (Cliniques universitaires Saint-Luc)

Introduced by Prof. Dr. Orsalia Alexopoulou (Cliniques universitaires Saint-Luc)

 

14:45-15:00       Award ceremony of the young investigators

                  Moderated by Prof. Dr. Laurent Crenier (HUB, Hôpital Erasme)